Global Veterinary Infectious Disease Diagnostics Market, By Technology (Immunodiagnostics, Molecular Diagnostics), By Animal-Type (Companion Animals, Food-Producing Animals), By End-User (Reference Laboratories, Veterinary Laboratories, and Clinics, Point of Care / In House Testing, Research Institutes and Universities), By Region (North America, Europe, Asia-Pacific (APAC), Latin America (LATAM), Middle-East & Africa (MEA) Trend Analysis, Competitive Market Share & Forecast, 2017-2027
- Published Date: May 2021
- Report ID: BWC19327
- Available Format: PDF
- Page: 125
Report Overview
Several contagious diseases affect companion animals. These diseases can prove deadly and can lead to severe complications if not treated promptly. Veterinary infectious disease diagnosis refers to the detection of infectious diseases in animals.Global Veterinary Infectious Disease Diagnostics Market- Industry Trends & Forecast Report 2027
The global veterinary infectious disease diagnostics market was worth USD 1.68 billion in 2020 and is further projected to reach USD 3.07 billion by the year 2027, growing at the CAGR of 9.2% during the forecast period (2020-2027). Rising technological advancement in diagnostic devices, automation, rising companion animal population coupled with the increasing trend of pet insurance is the key factor anticipated to propel the demand of the veterinary infectious disease diagnostics market in the forecast period. Also, rising investment in animal healthcare, increasing incidence of zoonotic diseases, rising disposable income in emerging economies will further drive the global veterinary infectious disease diagnostics.
Source: BlueWeave Consulting
Global Veterinary Infectious Disease Diagnostics Market: Overview
Several contagious diseases affect companion animals. These diseases can prove deadly and can lead to severe complications if not treated promptly. Veterinary infectious disease diagnosis refers to the detection of infectious diseases in animals. These diagnostics are often used to indirectly monitor human health as well. Monitoring and control of zoonotic disease, an infectious disease transmitted from animals to humans, is a crucial part of the veterinary infectious disease diagnostics market. This is important for food safety, sanitation, and the well-being of both domesticated animals as well as the owner.
Growth Drivers
Growing demand for advanced diagnostic devices
The rising demand for advanced veterinary infectious disease diagnostic technologies by professionals and practitioners is fueling the growth of the veterinary infectious disease diagnostics market. Advanced diagnostics devices such as nucleic acid diagnostics, biosensors, PCR, and biomarkers are increasingly being used for routine diagnostics. That is why manufacturing companies are increasingly focusing on research and development for launching new and better products which are technologically advanced and effective in diagnostics. These factors are expected to further propel the market during the forecast period.
Increasing Disease Control and Disease Prevention Measures
The growing prevalence of infectious diseases raises the risk of its spread in humans as well. Coronavirus is one of the most pertinent examples of this scenario. Therefore, governments around the world are undertaking a variety of programs to combat the rising prevalence of infectious diseases to prevent a pandemic-like situation in the future. Rising government spending on animal healthcare, along with advanced healthcare facilities, and stringent regulatory and policy reforms are all increasing the demand for effective veterinary infectious disease diagnosis.
Restraints
Increasing Pet Care Costs
Despite growing costs, pet owners are spending enough to properly care for their pets' health. However, with rising technological advancements, coupled with strict regulatory policies, and indirect reforms, the market may experience a setback during the forecast period. All these factors add to the overall cost of pet care and maintenance. With rising inflation, pet owners may try to cut down their overall expenses, which will directly affect the growth of the veterinary infectious disease diagnostics market.
Impact of Covid-19 on the Global Veterinary Infectious Disease Diagnostics Market
The global veterinary infectious disease diagnostics market witnessed tremendous growth since the outbreak of the COVID-19 pandemic. Coronavirus infection is a zoonotic disease that was first discovered in bats. Following the rapid spread of the virus and its global impact, public awareness regarding animal infection and zoonotic diseases increased. Pet owners also began diagnosing their animals regularly to avoid infection. As a result, demand for infectious disease diagnostics increased dramatically in order to avoid the spread of some other virus or pandemic scenario, thereby boosting market development.
Global Veterinary Infectious Disease Diagnostics Market: Technology
Based on technology, the global veterinary infectious disease diagnostics market is segregated into immunodiagnostics and molecular diagnostics. The rising emergence rate of advanced immunoassay formats and diagnostics is likely to contribute a major share to propel the growth of the immunodiagnostics segment in the global veterinary infectious disease diagnostic market during the forecast period. Advantages associated with advanced technologies such as quick, sensitive, and accurate diagnosis, high rate of efficacy, and accurate result validation, coupled with the rising incidence of infectious diseases are anticipated to support the growth of the global veterinary infectious disease diagnostics market in upcoming years.
Global Veterinary Infectious Disease Diagnostics Market: Animal Type
Based on animal type, the global veterinary infectious disease diagnostics market is segmented into companion animals and food-producing animals. The companion animals segment holds the largest market share. The highly infectious nature of viral diseases is a significant factor driving the demand for viral infection diagnosis in companion animals. Additionally, the rising number of pet owners due to the humanization of animals as well as the need for companionship contribute to the growth of this segment. Increasing bacterial infection and worm infestation incidences are also likely to contribute to the growing companion animal segment in the global veterinary infectious disease diagnostic market during the forecast period.
Global Veterinary Infectious Disease Diagnostics Market: End-User
Based on the end-user, the global veterinary infectious disease diagnostics market is segmented into reference laboratories, veterinary hospitals & clinics, point-of-care/in-house testing, and research institutes & universities. The reference laboratories accounted for the largest market share. Reference laboratories are private facilities that perform diagnosis and offer a wide variety of tests. These laboratories handle high volumes of routine testing due to which it has high demand in the veterinary infectious disease diagnostics market. Hospitals and clinics are also contributing to market growth because they are the first choice of animal owners for first-point care.
Global Veterinary Infectious Disease Diagnostics Market: Regional Insights
Geographically, the global veterinary infectious disease diagnostics market is segmented into North America, Europe, Asia-Pacific (APAC), Latin America, Middle-East & Africa. Among these regions, North America is expected to hold the largest market share followed by Europe due to factors such as favorable healthcare infrastructure and the availability of numerous market players in these regions. Furthermore, the availability of diagnostic devices, as well as increased pet ownership and growing healthcare spending, are driving market growth in North America. Additionally, increasing companion animal ownership, combined with favorable animal welfare policies, is expected to drive the North American market during the forecast period.
Competitive Landscape
The leading market players of the global veterinary infectious disease diagnostics market are Biomerieux S.A., Heska Corporation, IDEXX Laboratories, Inc., IDVet, Neogen Corporation, Boehringer Ingelheim Vetmedica, Inc., Dechra Pharmaceuticals PLC, Ceva Santé Animale, Bayer AG, Vetoquinol S.A, HESKA Corporation, Demeditec Diagnostics GmbH, and other prominent players.
The market players are constantly adopting growth strategies such as partnerships, mergers & acquisitions, etc., to expand their consumer base. They are also focusing on the launch of innovative and technologically advanced products to stay ahead of the curve.
Recent Developments
l In May 2021, The American Academy of Dermatology (AAD) reported a USD 7 million investment to extend the company's point-of-care target. This investment is geared toward One Health's agenda of promoting animal, human, and environmental health.
l In July 2020, LexaGene, a US-based molecular diagnostics company, announced the launch of a new genetic analyzer called ‘MiQLab. This technology can be used for performing real-time veterinary diagnostics testing at the point of care.
Scope of the Report
|
Attributes |
Details |
|
Years Considered |
Historical data – 2017-2020 Base Year – 2020 Forecast – 2021 – 2027 |
|
Facts Covered |
Revenue in USD Million |
|
Market Coverage |
North America, Europe, the Asia-Pacific, Latin America, and the Middle East and Africa |
|
Product Service/Segmentation |
By Technology, By Animal-Type, By End-User, By Region |
|
Key Players |
Biomerieux S.A., Heska Corporation, IDEXX Laboratories, Inc., IDVet, Neogen Corporation, QIAGEN N.V. (A Part of Indical Bioscience), Randox Laboratories, Ltd., Thermo Fisher Scientific, Virbac, Zoetis, Inc., Elanco, Merck & Co. Inc, Boehringer Ingelheim Vetmedica, Inc., Dechra Pharmaceuticals PLC, Ceva Santé Animale, Bayer AG, Vetoquinol S.A, HESKA Corporation, Demeditec Diagnostics GmbH, and other prominent players. |
By Technology
Ø Immunodiagnostics
Lateral Flow Assays
ELISA Tests
Other Immunodiagnostic Technologies
Ø Molecular Diagnostics
Polymerase Chain Reaction (PCR) Tests
Microarrays
Other Molecular Diagnostic Tests
By Animal Type
Ø Companion Animals
Ø Food-Producing Animals
By End-User
Ø Reference Laboratories
Ø Veterinary Laboratories and Clinics
Ø Point of Care / In House Testing
Ø Research Institutes and Universities
By Region
Ø North America
Ø Europe
Ø Asia-Pacific (APAC)
Ø Latin America (LATAM)
Ø Middle-East & Africa (MEA)
FAQs:
1. What is the current size of the global veterinary infectious disease diagnostics market?
Answer: The global veterinary infectious disease diagnostics market reached USD 1.68 billion in 2020.
2. What are the major factors driving the growth of the global veterinary infectious disease diagnostics market?
Answer: The major factors driving the growth of the global veterinary infectious disease diagnostics market are the growing demand for advanced diagnostic devices and increasing disease control and disease prevention measures.
3. Who are the key players in the global veterinary infectious disease diagnostics market?
Answer: The key players in the global veterinary infectious disease diagnostics market are Biomerieux S.A., Heska Corporation, IDEXX Laboratories, Inc., IDVet, Neogen Corporation, QIAGEN N.V. (A Part of Indical Bioscience), Randox Laboratories, Ltd., Thermo Fisher Scientific, Virbac, Zoetis, Inc., Elanco, Merck & Co. Inc, Boehringer Ingelheim Vetmedica, Inc., Dechra Pharmaceuticals PLC, Ceva Santé Animale, Bayer AG, Vetoquinol S.A, HESKA Corporation, Demeditec Diagnostics GmbH, and other prominent players.
4. Which animal-type segment accounted for the largest share in the global veterinary infectious disease diagnostics market?
Answer: The companion animals segment accounted for the largest share in the global veterinary infectious disease diagnostics market.
5. Which region is at the highest growth rate in the global veterinary infectious disease diagnostics market?
Answer: North America has the largest share in the global veterinary infectious disease diagnostics market.
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Research Methodology
2.1. Qualitative Research
2.1.1. Primary and Secondary Sources
2.2. Quantitative Research
2.2.1. Primary and Secondary Sources
2.3. Breakdown of Primary Research Respondents
2.3.1. Secondary Research
2.3.2. Primary Research
2.4. Breakdown of Primary Research Respondents, By Industry Participants
2.5. Key Questionnaire asked during Primary Interviews
2.6. Key Primary Responses
2.7. Market Size Estimation
2.8. Assumption for the Study
2.9. Market Breakdown & Data Triangulation
3. Executive Summary
4. Global Veterinary Infectious Disease Diagnostics Market – Industry Insights
4.1. DROC Analysis
4.1.1. Growth Drivers
4.1.2. Restraints
4.1.3. Opportunity
4.1.4. Challenges
4.2. Recent Developments / Technical Landscape
4.3. Regulatory Framework
4.4. Porter’s Five Forces Analysis
4.5. Value Chain Analysis
4.6. Strategic Outlook
5. Global Veterinary Infectious Disease Diagnostics Market Overview
5.1. Market Estimates & Forecast by Value, 2017-2027
5.1.1. By Value (USD Million)
5.2.1. By Technology
5.2.1.1. Immunodiagnostics
5.2.1.1.1. Lateral Flow Assays
5.2.1.1.2. ELISA Tests
5.2.1.1.3. Other Immunodiagnostic Technologies
5.2.1.2. Molecular Diagnostics
5.2.1.2.1. Polymerase Chain Reaction (PCR) Tests
5.2.1.2.2. Microarrays
5.2.1.2.3. Other Molecular Diagnostic Tests
5.2.2. By Animal Type
5.2.2.1. Companion Animals
5.2.2.2. Food Producing Animals
5.2.3. By End User
5.2.3.1. Reference Laboratories
5.2.3.2. Veterinary Laboratories and Clinics
5.2.3.3. Point of Care / In House Testing
5.2.3.4. Research Institutes and Universities
5.2.4. By Region
5.2.4.1. North America
5.2.4.2. Europe
5.2.4.3. Asia-Pacific (APAC)
5.2.4.4. Latin America (LATAM)
5.2.4.5. Middle-East & Africa (MEA)
6. North America Veterinary Infectious Disease Diagnostics Market Overview
6.1. Market Size and Forecast
6.1.1. By Value (USD Million), 2017-2027
6.2. Market Share and Forecast
6.2.1. By Technology
6.2.2. By Animal-Type
6.2.3. By End-User
6.2.4. By Country
6.2.4.1. U.S.
6.2.4.2. Canada
7. Europe Veterinary Infectious Disease Diagnostics Market Overview
7.1. Market Size and Forecast
7.1.1. By Value (USD Million), 2017-2027
7.2. Market Share and Forecast
7.2.1. By Technology
7.2.2. By Animal-Type
7.2.3. By End-User
7.2.4. By Country
7.2.4.1. Germany
7.2.4.2. U.K.
7.2.4.3. France
7.2.4.4. Italy
7.2.4.5. Spain
7.2.4.6. Russia
7.2.4.7. Netherlands
7.2.4.8. Rest of Europe
8. APAC Veterinary Infectious Disease Diagnostics Market Overview
8.1. Market Size and Forecast
8.1.1. By Value (USD Million), 2017-2027
8.2. Market Share and Forecast
8.2.1. By Technology
8.2.2. By Animal-Type
8.2.3. By End-User
8.2.4. By Country
8.2.4.1. China
8.2.4.2. India
8.2.4.3. Japan
8.2.4.4. South Korea
8.2.4.5. Rest of APAC
9. LATAM Veterinary Infectious Disease Diagnostics Market Overview
9.1. Market Size and Forecast
9.1.1. By Value (USD Million), 2017-2027
9.2. Market Share and Forecast
9.2.1. By Technology
9.2.2. By Animal-Type
9.2.3. By End-User
9.2.4. By Country
9.2.4.1. Mexico
9.2.4.2. Brazil
9.2.4.3. Rest of LATAM
10.MEA Veterinary Infectious Disease Diagnostics Market Overview
10.1. Market Size and Forecast
10.1.1. By Value (USD Million), 2017-2027
10.2. Market Share and Forecast
10.2.1. By Technology
10.2.2. By Animal-Type
10.2.3. By End-User
10.2.4. By Country
10.2.4.1. Saudi Arabia
10.2.4.2. UAE
10.2.4.3. South Africa
10.2.4.4. Turkey
10.2.4.5. Rest of Europe
11.Competitive Landscape
11.1.1. List of Key Players and Their Offerings
11.1.2. Market Share / Ranking Analysis (2020)
11.1.3. Competitive Benchmarking, By Operating Parameters
12.COVID-19 Impact
12.1. Future Impact
12.2. Key Developments during COVID-19
12.3. Impact on Market
12.3.1. Different Scenario
12.3.2. Impact on Companies
12.4. Regional Impact
13.Company Profiles (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) *
13.1. Biomerieux S.A.
13.2. Heska Corporation
13.3. IDEXX Laboratories, Inc.
13.4. IDVet
13.5. Neogen Corporation
13.6. QIAGEN N.V. (A Part of Indical Bioscience)
13.7. Randox Laboratories, Ltd.
13.8. Thermo Fisher Scientific
13.9. Virbac
13.10. Zoetis, Inc.
13.11. Elanco
13.12. Merck & Co. Inc
13.13. Boehringer Ingelheim Vetmedica, Inc.
13.14. Dechra Pharmaceuticals PLC
13.15. Ceva Santé Animale
13.16. Bayer AG
13.17. Vetoquinol S.A
13.18. HESKA Corporation
13.19. Demeditec Diagnostics GmbH
13.20. Other Prominent Players
14.Key Strategic Recommendations
* Financial information of non-listed Companies will be provided as per availability
**The segmentation and the companies are subjected to modifications based on in-depth study during the final deliverable.
List of Figures
Fig: Global Veterinary Infectious Disease Diagnostics Segmentation
Fig: Global Veterinary Infectious Disease Diagnostics Market Value Chain Analysis,
Fig: Company Market Share Analysis, 2020
Fig: Global Veterinary Infectious Disease Diagnostics Market Size, By Value (USD Million), 2017-2027
Fig: Global Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, By Value, 2017-2027
Fig: Global Veterinary Infectious Disease Diagnostics Market Share (%), By Animal-Type, By Value, 2017-2027
Fig: Global Veterinary Infectious Disease Diagnostics Market Share (%), By End-User, By Value, 2017-2027
Fig: Global Veterinary Infectious Disease Diagnostics Market Share (%), By Country, By Value, 2017-2027
Fig: North America Veterinary Infectious Disease Diagnostics Market Size, By Value (USD Million), 2017-2027
Fig: North America Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, By Value, 2017-2027
Fig: North America Veterinary Infectious Disease Diagnostics Market Share (%), By Animal-Type, By Value, 2017-2027
Fig: North America Veterinary Infectious Disease Diagnostics Market Share (%), By End-User, By Value, 2017-2027
Fig: North America Veterinary Infectious Disease Diagnostics Market Share (%), By Country, By Value, 2017-2027
Fig: Europe Veterinary Infectious Disease Diagnostics Market Size, By Value (USD Million), 2017-2027
Fig: Europe Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, By Value, 2017-2027
Fig: Europe Veterinary Infectious Disease Diagnostics Market Share (%), By Animal-Type, By Value, 2017-2027
Fig: Europe Veterinary Infectious Disease Diagnostics Market Share (%), By End-User, By Value, 2017-2027
Fig: Europe Veterinary Infectious Disease Diagnostics Market Share (%), By Country, By Value, 2017-2027
Fig: the Asia-Pacific Veterinary Infectious Disease Diagnostics Market Size, By Value (USD Million), 2017-2027
Fig: the Asia-Pacific Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, By Value, 2017-2027
Fig: the Asia-Pacific Veterinary Infectious Disease Diagnostics Market Share (%), By Animal-Type, By Value, 2017-2027
Fig: the Asia-Pacific Veterinary Infectious Disease Diagnostics Market Share (%), By End-User, By Value, 2017-2027
Fig: Asia-Pacific Veterinary Infectious Disease Diagnostics Market Share (%), By Country, By Value, 2017-2027
Fig: Latin America Veterinary Infectious Disease Diagnostics Market Size, By Value (USD Million), 2017-2027
Fig: Latin America Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, By Value, 2017-2027
Fig: Latin America Veterinary Infectious Disease Diagnostics Market Share (%), By Animal-Type, By Value, 2017-2027
Fig: Latin America Veterinary Infectious Disease Diagnostics Market Share (%), By End-User, By Value, 2017-2027
Fig: Latin America Veterinary Infectious Disease Diagnostics Market Share (%), By Country, By Value, 2017-2027
Fig: Middle East & Africa Veterinary Infectious Disease Diagnostics Market Size, By Value (USD Million), 2017-2027
Fig: Middle East & Africa Veterinary Infectious Disease Diagnostics Market Share (%), By Technology, By Value, 2017-2027
Fig: Middle East & Africa Veterinary Infectious Disease Diagnostics Market Share (%), By Animal-Type, By Value, 2017-2027
Fig: Middle East & Africa Veterinary Infectious Disease Diagnostics Market Share (%), By End-User, By Value, 2017-2027
Fig: Middle East & Africa Veterinary Infectious Disease Diagnostics Market Share (%), By Region, By Value, 2017-2027
List of Tables
Table: Global Veterinary Infectious Disease Diagnostics Market Size, By Technology, By Value, 2017-2027
Table: Global Veterinary Infectious Disease Diagnostics Market Size, By Animal-Type, By Value (USD Million), 2017-2027
Table: Global Veterinary Infectious Disease Diagnostics Market Size, By End-User, By Value (USD Million), 2017-2027
Table: Global Veterinary Infectious Disease Diagnostics Market Size, By Region, By Value (USD Million), 2017-2027
Table: North America Veterinary Infectious Disease Diagnostics Market Size, By Technology, By Value (USD Million), 2017-2027
Table: North America Veterinary Infectious Disease Diagnostics Market Size, By Animal-Type, By Value (USD Million), 2017-2027
Table: North America Veterinary Infectious Disease Diagnostics Market Size, By End-User, By Value (USD Million), 2017-2027
Table: North America Veterinary Infectious Disease Diagnostics Market Size, By Country, By Value (USD Million), 2017-2027
Table: Europe Veterinary Infectious Disease Diagnostics Market Size, By Technology, By Value (USD Million), 2017-2027
Table: Europe Veterinary Infectious Disease Diagnostics Market Size, By Animal-Type, By Value (USD Million), 2017-2027
Table: Europe Veterinary Infectious Disease Diagnostics Market Size, By End-User, By Value (USD Million), 2017-2027
Table: Europe Veterinary Infectious Disease Diagnostics Market Size, By Country, By Value (USD Million), 2017-2027
Table: the Asia-Pacific Veterinary Infectious Disease Diagnostics Market Size, By Technology, By Value (USD Million), 2017-2027
Table: the Asia-Pacific Veterinary Infectious Disease Diagnostics Market Size, By Animal-Type, By Value (USD Million), 2017-2027
Table: the Asia-Pacific Veterinary Infectious Disease Diagnostics Market Size, By End-User, By Value (USD Million), 2017-2027
Table: the Asia-Pacific Veterinary Infectious Disease Diagnostics Market Size, By Country, By Value (USD Million), 2017-2027
Table: Latin America Veterinary Infectious Disease Diagnostics Market Size, By Technology, By Value (USD Million), 2017-2027
Table: Latin America Veterinary Infectious Disease Diagnostics Market Size, By Animal-Type, By Value (USD Million), 2017-2027
Table: Latin America Veterinary Infectious Disease Diagnostics Market Size, By End-User, By Value (USD Million), 2017-2027
Table: Latin America Veterinary Infectious Disease Diagnostics Market Size, By Country, By Value (USD Million), 2017-2027
Table: The Middle-East & Africa Veterinary Infectious Disease Diagnostics Market Size, By Technology, By Value (USD Million), 2017-2027
Table: The Middle-East & Africa Veterinary Infectious Disease Diagnostics Market Size, By Animal-Type, By Value (USD Million), 2017-2027
Table: The Middle-East & Africa Veterinary Infectious Disease Diagnostics Market Size, By End-User, By Value (USD Million), 2017-2027
Table: The Middle-East & Africa Veterinary Infectious Disease Diagnostics Market Size, By Country, By Value (USD Million), 2017-2027
Table: Biomerieux S.A. Financial Analysis
Table: Biomerieux S.A. Business Overview
Table: Heska Corporation Financial Analysis
Table: Heska Corporation Corporation Business Overview
Table: IDEXX Laboratories, Inc. Financial Analysis
Table: IDEXX Laboratories, Inc. Business Overview
Table: IDVet Financial Analysis
Table: IDVet Business Overview
Table: Neogen Corporation Financial Analysis
Table: Neogen Corporation Business Overview
Table: QIAGEN N.V. Financial Analysis
Table: QIAGEN N.V. Business Overview
Table: Randox Laboratories, Ltd. Financial Analysis
Table: Randox Laboratories, Ltd. Business Overview
Table: Thermo Fisher Scientific Financial Analysis
Table: Thermo Fisher Scientific Business Overview
Table: Virbac Financial Analysis
Table: Virbac Business Overview
Table: Zoetis, Inc. Financial Analysis
Table: Zoetis, Inc. Business Overview
Table: Merck & Co. Inc Financial Analysis
Table: Merck & Co. Inc Financial Analysis
Table: Boehringer Ingelheim Vetmedica, Inc. Financial Analysis
Table: Boehringer Ingelheim Vetmedica, Inc. Business Overview
Table: Dechra Pharmaceuticals PLC Financial Analysis
Table: Dechra Pharmaceuticals PLC Business Overview
Table: Ceva Santé Animale Financial Analysis
Table: Ceva Santé Animale Business Overview
Table: Bayer AG Financial Analysis
Table: Bayer AG Business Overview
Table: Vetoquinol S.A Financial Analysis
Table: Vetoquinol S.A Business Overview
Table: HESKA Corporation Financial Analysis
Table: HESKA Corporation Business Overview
Table: Demeditec Diagnostics GmbH Financial Analysis
Table: Demeditec Diagnostics GmbH Business Overview
Table: Elanco Financial Analysis
Table: Elanco Business Overview
Market Segmentation
By Technology
- Immunodiagnostics
Lateral Flow Assays
ELISA Tests
Other Immunodiagnostic Technologies
- Molecular Diagnostics
Polymerase Chain Reaction (PCR) Tests
Microarrays
Other Molecular Diagnostic Tests
By Animal Type
- Companion Animals
- Food-Producing Animals
By End-User
- Reference Laboratories
- Veterinary Laboratories and Clinics
- Point of Care / In House Testing
- Research Institutes and Universities
By Region
- North America
- Europe
- Asia-Pacific (APAC)
- Latin America (LATAM)
- Middle-East & Africa (MEA)
To request a free sample copy of this report, please complete the form below.
We value your investment and offer free customization with every report to fulfil your exact research needs.
RELATED REPORTS
WHY CHOOSE US
-
24/7 Research support
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
-
Coustom Research Service
Ask the Analyst to customize an exclusive study to serve your research needs
-
Quality & Accuracy
Ask the Analyst to customize an exclusive study to serve your research needs
-
Data Visualization
As the business world is changing dynamically every day. We need to stay pin point in relation to data management and optimum data utilization
-
Information security
We never share your personal and confidential information. Your personal information is safe and secure with us.